sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> ulcerative colitis market

report

Ulcerative Colitis Market, by Disease Type (Mild Ulcerative Colitis, Moderate Ulcerative Colitis, Severe Ulcerative Colitis), Molecule Type (Biologics, Small Molecules), Route of Administration (Oral, Injectables) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC411 October 2017 100+ FREE 10% CUSTOMIZATION

Ulcerative Colitis (UC) may be a chronic, enfeebling unwellness that affects intestine or colon. The reason for colitis is unknown but, researchers believe that it's associate exaggerated response to a microbic trigger. UC is characterised by inflammation within the colon, and its symptoms embody blood within the stool, diarrhea, and abdominal pain. The treatment of UC includes ancient therapies like medicine product of growth gangrene issue (TNF) inhibitors and tiny molecule. internal organ unwellness} may be a kind of inflammatory bowel disease (IBD) that affects the colon and body part a part of anatomy. Inflammation and ulcers area unit fashioned within the innermost lining of the colon and body part, leading to the assembly of pus and mucose in these linings. Abdominal cramps, diarrhea, and body part hurt area unit among the common symptoms determined in people suffering with the unwellness.

The report on the global ulcerative colitis market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The factor that boosts the expansion of worldwide {ulcerative colitis|colitis|inflammatory bowel unwellness} market area unit growing prevalence of colitis disease that affects several individuals globally. additionally, vast R&D and investment done by key players towards development of novel therapies for UC treatment and rise in government and non-government organizations towards analysis in biologics any fuels the market growth.
  • However, patent end of medicine and demanding government rules towards approval of biosimilars restrain the market growth. Unmet wants within the treatment of UC give moneymaking growth opportunities for the expansion of the market. The high prevalence of {ulcerative colitis|colitis|inflammatory bowel unwellness} disease in India drives the expansion of the colitis market.
  • Moreover, health care infrastructural advancements and enlargement of drug development sector any fuels the market growth within the country. additionally, strong government initiative toward improvement of health care facilities through favorable insurance schemes is anticipated to produce moneymaking growth opportunities within the country.

Regionally, the global ulcerative colitis market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, the lack of curative medical aid and personalised medical aid area unit huge opportunities for the market. North America, particularly the US, accounted for the biggest market share. The Europe and Asia-Pacific markets area unit expected to grow at a better CAGR throughout the forecast amount. In Asia-Pacific, China leads the market. Economic development and betterment of health care facilities area unit dynamic the expansion of the market. The entry of Simponi and Entyvio is probably going to fuel the expansion of the market. However, Humira can lose its patent in 2016 and Remicade in 2018 and can not have a positive impact on the market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s ulcerative colitis market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the ulcerative colitis market by the following segments:

  • Ulcerative Colitis Market, by Disease Type
    • Mild Ulcerative Colitis
    • Moderate Ulcerative Colitis
    • Severe Ulcerative Colitis
  • Ulcerative Colitis Market, by Molecule Type
    • Biologics
    • Small Molecules
  • Ulcerative Colitis Market, by Route of Administration
    • Oral
    • Injectables

KEY MARKET PLAYERS

Key players in the ulcerative colitis market include:

  • Pfizer Inc.
  • Johnson & Johnson
  • Glaxosmithkline Plc
  • Eli Lilly and co.
  • Sanofi Aventis A/S
  • Astrazeneca Plc
  • Merck & co. Inc.
  • Abbott Laboratories
  • Index Pharmaceuticals Holding Ab
  • Ajinomoto Pharmaceuticals Co., ltd.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Healthcare Business Process Outsourcing (BPO) Market, by Provider Service (Medical Billing, Medical Coding, Medical Transcription and Others), Payer Services (Member Management Services, Claims Management Services, Provider Management Services and Others), Pharmaceutical Services (Research And Development, Manufacturing and Non-Clinical Services) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. ULCERATIVE COLITIS MARKET, BY DISEASE TYPE
    1. Segment Share
    2. By Disease Type
      1. Mild Ulcerative Colitis
      2. Moderate Ulcerative Colitis
      3. Severe Ulcerative Colitis
  6. ULCERATIVE COLITIS MARKET, BY MOLECULE TYPE
    1. Segment Share
    2. By Molecule Type
      1. Biologics
      2. Small Molecules
  7. ULCERATIVE COLITIS MARKET, BY ROUTE OF ADMINISTRATION
    1. Segment Share
    2. By Route of Administration
      1. Oral
      2. Injectables
  8. ULCERATIVE COLITIS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Disease Type
      3. By Molecule Type
      4. By Route of Administration
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Disease Type
      3. By Molecule Type
      4. By Route of Administration
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Disease Type
      3. By Molecule Type
      4. By Route of Administration
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Disease Type
      3. By Molecule Type
      4. By Route of Administration
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  10. KEY MARKET PLAYERS
    1. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Johnson & Johnson
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Glaxosmithkline Plc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Eli Lilly and co.
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Sanofi Aventis A/S
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Astrazeneca Plc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Merck & co. Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Index Pharmaceuticals Holding Ab
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Ajinomoto Pharmaceuticals Co., ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us